Clinical Trial

Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
A Study of STM-416p Administered Intraoperatively to Patients Undergoing Radical Prostatectomy
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-06-06; most recent amendment 2026-02-17.
Status change: Not Yet Recruiting → Recruiting 2025-05-20
Trial Details
NCT Number NCT06450106
Lead Sponsor SURGE Therapeutics
Conditions Prostate Cancer
Enrollment 18 participants
Start Date 2025-05-08
Primary Completion 2026-09 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-19